PT - JOURNAL ARTICLE AU - Argueta, Donovan A AU - Tran, Huy AU - Goel, Yugal AU - Nguyen, Aithanh AU - Nguyen, Julia AU - Kiven, Stacy B AU - Chen, Chunsheng AU - Abdulla, Fuad AU - Vercellotti, Gregory M AU - Belcher, John D AU - Gupta, Kalpna TI - Mast cell extracellular trap formation underlies vascular and neural injury and hyperalgesia in sickle cell disease AID - 10.26508/lsa.202402788 DP - 2024 Nov 01 TA - Life Science Alliance PG - e202402788 VI - 7 IP - 11 4099 - https://www.life-science-alliance.org/content/7/11/e202402788.short 4100 - https://www.life-science-alliance.org/content/7/11/e202402788.full SO - Life Sci. Alliance2024 Nov 01; 7 AB - Sickle cell disease (SCD) is the most common inherited monogenetic disorder. Chronic and acute pain are hallmark features of SCD involving neural and vascular injury and inflammation. Mast cells reside in the vicinity of nerve fibers and vasculature, but how they influence these structures remains unknown. We therefore examined the mechanism of mast cell activation in a sickle microenvironment replete with cell-free heme and inflammation. Mast cells exposed to this environment showed an explosion of nuclear contents with the release of citrullinated histones, suggestive of mast cell extracellular trap (MCET) release. MCETs interacted directly with the vasculature and nerve fibers, a cause of vascular and neural injury in sickle cell mice. MCET formation was dependent upon peptidylarginine deiminase 4 (PAD4). Inhibition of PAD4 ameliorated vasoocclusion, chronic and acute hyperalgesia, and inflammation in sickle mice. PAD4 activation may also underlie neutrophil trap formation in SCD, thus providing a novel target to treat the sequelae of vascular and neural injury in SCD.